Case Study: Pr3vent Medical screens 10X more newborns for preventable vision loss with Provectus AI

Pr3vent Medical reduces eye screening costs by 10X with Provectus

Pr3vent Medical, a medical AI diagnostic company, faced the challenge of screening millions of newborns for preventable vision loss, a task hindered by a critical shortage of qualified ophthalmologists. To extend this expertise, Pr3vent partnered with Provectus to turn its exclusive dataset of retinal images into an FDA-ready AI screening platform.

Provectus built a custom labeling system, an AI platform, and a physician screening application. This solution reduced the cost per eye screening by 10X and achieved 96% diagnostic accuracy, enabling the same number of specialists to support a vastly larger population of infants and potentially saving billions in societal costs.

Pr3vent Medical